Connective Tissue Diseases  >>  Mifeprex (mifepristone)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mifeprex (mifepristone) / Danco Laboratories
Mifemyo, NCT00712595: Mifepristone for Treatment of Uterine Fibroids

Checkmark
Sep 2013 - Sep 2013: 
Completed
2/3
200
RoW
Mifepristone, Low doses of antiprogestins to treat uterine fibroids.
Mediterranea Medica S. L.
Uterine Fibroids
01/07
03/09
Mifemyo_2, NCT00886873: Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids

Completed
2/3
100
RoW
Mifepristone
Mediterranea Medica S. L.
Uterine Fibroids
04/09
05/09
NCT01786226: Mifepristone to Treat Uterine Fibroids

Checkmark
Aug 2013 - Aug 2013: 
Terminated
2/3
220
RoW
Oral administration of mifepristone 2.5 mg daily for three months, Low doses of antiprogestins to treat uterine fibroids, Oral administration of mifepristone 5 mg daily for three months
Mediterranea Medica S. L.
Uterine Fibroids
03/12
03/12

Download Options